Stay updated on Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial
Sign up to get notified when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.

Latest updates to the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page
- Check2 days agoChange DetectedAccess to the study record has been replaced by a 403 Forbidden error page, effectively removing the study details and navigation from view. The page now shows a standard 403 message along with site chrome (Home link and footer).SummaryDifference21%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRelated topics were added to the page, including a 'Multiple myeloma' entry and a MedlinePlus Genetics link, under the related topics section to aid navigation.SummaryDifference0.1%

- Check23 days agoChange DetectedFooter text updated to Revision: v3.6.6; deleted older references to 'Multiple myeloma', 'related topics:', 'MedlinePlus Genetics', and the previous revision tag 'Revision: v3.6.5'.SummaryDifference0.2%

- Check30 days agoChange DetectedMultiple myeloma is now listed as a topic on the page, and a Related topics entry for MedlinePlus Genetics has been added.SummaryDifference0.1%

- Check37 days agoChange Detected- Removed the 'Multiple myeloma' label and the 'MedlinePlus Genetics' link from the related topics area. This reduces disease-specific context and removes a genetics resource for users.SummaryDifference0.1%

- Check45 days agoChange DetectedMultiple myeloma and MedlinePlus Genetics were added as related topics, expanding the page's linked resources. The site revision was updated to v3.6.5 from v3.6.4.SummaryDifference0.2%

Stay in the know with updates to Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.